SCHEMBL23249702

SCHEMBL23249702

CC(=O)OC(C)C(C)OS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.40
TLR9 Q9NR96 1/20 0.40
MAPK1 P28482 1/20 0.40
GAA P10253 2/20 0.39
PKM P14618 1/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
MMP1 P03956 2/20 0.38
MMP2 P08253 2/20 0.38
MMP9 P14780 2/20 0.38
MMP13 P45452 2/20 0.38
MMP8 P22894 1/20 0.38
ALDH1A1 P00352 3/20 0.38
POLB P06746 1/20 0.38
DHODH Q02127 1/20 0.37
VDR P11473 1/20 0.37
CA12 O43570 1/20 0.37
CA3 P07451 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23249700 1.00 LMNA (0.40) LMNATLR9MAPK1GAAPKM
SCHEMBL2342945 0.86 GAA (0.52) LMNATLR9MAPK1GAAKMT2A
SCHEMBL5557903 0.86 GAA (0.52) LMNATLR9MAPK1GAAKMT2A
SCHEMBL24806482 0.84 MAPK1 (0.40) LMNATLR9MAPK1GAAPKM
SCHEMBL23249579 0.83 POLB (0.40) LMNATLR9MAPK1GAAKMT2A
SCHEMBL23249580 0.83 POLB (0.40) LMNATLR9MAPK1GAAKMT2A
SCHEMBL31688093 0.81 LMNA (0.37) LMNAMAPK1GAAPKMKMT2A
SCHEMBL6686680 0.80 LMNA (0.40) LMNAMAPK1GAAPKMKMT2A
SCHEMBL10806036 0.79 GAA (0.42) LMNATLR9GAAPKMKMT2A
SCHEMBL10934289 0.79 TLR9 (0.45) LMNATLR9MAPK1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12281076-B2 Process for synthesis of picolinamides CORTEVA AGRISCIENCE LLC (US) 2025-04-22 US disclosed
US-20220411375-A1 PROCESS FOR SYNTHESIS OF PICOLINAMIDES CORTEVA AGRISCIENCE LLC (US) 2022-12-29 US disclosed
EP-4044811-A1 PROCESS FOR SYNTHESIS OF PICOLINAMIDES Corteva Agriscience LLC (US) 2022-08-24 EP disclosed
WO-2021076681-A1 PROCESS FOR SYNTHESIS OF PICOLINAMIDES DOW AGROSCIENCES LLC (US) 2021-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411375-A1 PROCESS FOR SYNTHESIS OF PICOLINAMIDES NPEPPS, ANPEP, DNPEP LMNA 989/4885TLR9 4687/4885MAPK1 4349/4885
US-12281076-B2 Process for synthesis of picolinamides NPEPPS, ANPEP, DNPEP LMNA 989/4885TLR9 4687/4885MAPK1 4349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.